Publicaciones > 2010 > Volumen 26 - Nº 3 > Esquemas Actuales de Tratamiento Farmacológico y Profilaxis para la Endocarditis Infecciosa

Cardiología Clínica 2010, Volumen 26 - Nº 3

2010

Esquemas Actuales de Tratamiento Farmacológico y Profilaxis para la Endocarditis Infecciosa

Depto. Cardiovascular, Hospital Clínico, Universidad de Chile

Índice
ESQUEMAS DE TRATAMIENTO ANTIBIÓTICO Y PROFILAXIS EN ENDOCARDITIS INFECCIOSA

TABLA 1. CLASES DE RECOMENDACIONES
TABLA 2. NIVELES DE EVIDENCIA
TABLA 3. ESTREPTOCOCO ORAL Y GRUPO D
TABLA 4. ENTEROCOCO
TABLA 5. ESTAFILOCOCOS
TABLA 6. GRUPO HACEK
TABLA 7. PATÓGENOS INHABITUALES
TABLA 8. EMPÍRICO SIN GERMEN CONOCIDO
TABLA 9. CRITERIOS PARA CONSIDERAR TRATAMIENTO EN DOMICILIO
TABLA 10. PROFILAXIS

 
 Descargar Tabla 1

 

 
 Descargar Tabla 2

 

 
 Descargar Tabla 3

 

 
 Descargar Tabla 4

 

 

 
 Descargar Tabla 5

 

 

 
 Descargar Tabla 6

 

 
 Descargar Tabla 7

 

 
 Descargar Tabla 8

 
 Descargar Tabla 9

 

 
 Descargar Figura 10


Bibliografía:
– Baddour LM, Wilson WR, Bayer AS, et al.  Infective Endocarditis. Diagnosis, Antimicrobial therapy and Management of Complications. A Statement for Healthcare Professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Counsil on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association (Endorsed by the Infectious Diseases Society of America). Circulation 2005; 111:e394-e433.
– Wilson WR, Taubert KA, Gewitz M, et al.  Prevention of Infective Endocarditis: Guidelines From the American Heart Association. A Guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 115: 1690-1695.
– Horstkotte D, Follath F, Gutshick E, et al. Guidelines on prevention, diagnosis and treatment of Infective Endocarditis executive summary; the task force on Infective Endocarditis of the European Society of Cardiology. Eur Heart J 2004; 25:267-276
– Habib G. Management of Infective. Endocarditis. Heart 2006; 92: 124-130.
– Nishimura RA, Carabello BA, Faxon DP. ACC7AHA 2008 Guideline update on Valvular Heart Disease: Focused Update on Infective Endocarditis: A report of the American College of Cardiology/American Heart Association task force on Practical Guidelines. Circulation 2008; 118: 887-896.
– Infective Endocarditis. Thomas F. Keys in Disease Management Project. The Cleveland Clinic Center for Continuing Education. Copyright 2000-2009. The Cleveland Clinic Foundation.
– Duval X, Leport C.  Prophylaxis of Infective Endocarditis: current tendencies, continuing controversies. Lancet Infect Dis 2008; 8: 225-232.
– Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaborative Study on Endocarditis-ProspectiveCohort Study. Arch Intern Med 2009; 169:463-473. 
– Shanson D. New British and American guidelines for the antibiotic prophylaxis of infective endocarditis: do the changes make sense? A critical review. Curr Opin Infect Dis 2008; 21:191-199.